Heart Failure Specialists are dedicated to the comprehensive care of individuals living with weakened or inefficient heart function. These experts employ a range of diagnostic and therapeutic strategies, from detailed imaging and lab tests to personalized medication regimens, to manage both the symptoms and root causes of heart failure. They are skilled in identifying early warning signs and tailoring treatment plans that may include diuretics, beta-blockers, ACE inhibitors, or more advanced solutions like cardiac resynchronization therapy or left ventricular assist devices.
A key strength of heart failure specialists lies in their long-term approach to patient care. They work closely with individuals to slow disease progression, minimize hospital visits, and improve overall quality of life. Their role often involves coordinating with other healthcare professionals to ensure patients receive cohesive, multi-disciplinary care. Education and lifestyle guidance are also integral parts of their practice, helping patients make informed decisions about diet, activity levels, and symptom management. Through proactive monitoring and evidence-based treatment, these specialists aim to give patients the best possible outcome, even with a chronic and often progressive condition like heart failure. Their expertise is essential in helping patients live longer, more fulfilling lives despite serious cardiac challenges. With each personalized plan, they offer both medical solutions and renewed hope for a healthier future.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India